Literature DB >> 15135846

A case-control study on adverse effects: H2 blocker or proton pump inhibitor use and risk of vitamin B12 deficiency in older adults.

Robert J Valuck1, J Mark Ruscin.   

Abstract

OBJECTIVE: Acid-suppressant drugs are commonly prescribed for elderly patients, a population in which vitamin B(12) deficiency is a common disorder. The purpose of this study was to examine the possible association between use of prescription histamine H-2 receptor antagonists (H2RA) or proton pump inhibitors (PPI) and vitamin B(12) deficiency in older adults. STUDY DESIGN AND
SETTING: This was a case-control study in a University-based geriatric primary care setting. Among patients aged 65 years or older with documented serum vitamin B(12) studies between 1990 and 1997, 53 vitamin B(12)-deficient cases were compared with 212 controls for past or current use of prescription H2RA/PPI according to information in subjects' medical records.
RESULTS: Controlling for age, gender, multivitamin use, and Helicobacter pylori infection, chronic (#10878;12 months) current use of H2RA/PPI was associated with a significantly increased risk of vitamin B(12) deficiency (OR 4.45; 95% CI 1.47-13.34). No association was found between past or short-term current use of H2RA/PPI and vitamin B(12) deficiency.
CONCLUSION: These findings support an association between chronic use of H2RA/PPI by older adults and development of vitamin B(12) deficiency. Additional studies are needed to confirm these findings.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15135846     DOI: 10.1016/j.jclinepi.2003.08.015

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  56 in total

1.  Overutilization of proton-pump inhibitors: what the clinician needs to know.

Authors:  Joel J Heidelbaugh; Andrea H Kim; Robert Chang; Paul C Walker
Journal:  Therap Adv Gastroenterol       Date:  2012-07       Impact factor: 4.409

2.  Comparisons of plasma/serum micronutrients between Okinawan and Oregonian elders: a pilot study.

Authors:  Hiroko H Dodge; Yuriko Katsumata; Hidemi Todoriki; Shoutoku Yasura; D Craig Willcox; Gene L Bowman; Bradley Willcox; Scott Leonard; Aaron Clemons; Barry S Oken; Jeffrey A Kaye; Maret G Traber
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2010-07-19       Impact factor: 6.053

Review 3.  Potential harms of proton pump inhibitor therapy: rare adverse effects of commonly used drugs.

Authors:  Amine Benmassaoud; Emily G McDonald; Todd C Lee
Journal:  CMAJ       Date:  2015-11-23       Impact factor: 8.262

4.  Long-term proton pump inhibitor use in children: a retrospective review of safety.

Authors:  V Tolia; K Boyer
Journal:  Dig Dis Sci       Date:  2007-08-04       Impact factor: 3.199

5.  Good primary care is obesity medicine.

Authors:  Ingrid Kohlstadt
Journal:  MedGenMed       Date:  2007-11-26

Review 6.  Risk factors for gastrointestinal complications in aspirin users: review of clinical and experimental data.

Authors:  Felix W Leung
Journal:  Dig Dis Sci       Date:  2008-02-28       Impact factor: 3.199

Review 7.  Potential adverse effects of proton pump inhibitors.

Authors:  Gregory A Coté; Colin W Howden
Journal:  Curr Gastroenterol Rep       Date:  2008-06

8.  Vitamin B12 Deficiency Induced by the Use of Gastric Acid Inhibitors: Calcium Supplements as a Potential Effect Modifier.

Authors:  N Presse; S Perreault; M-J Kergoat
Journal:  J Nutr Health Aging       Date:  2016       Impact factor: 4.075

Review 9.  Proton Pump Inhibitors, H2-Receptor Antagonists, Metformin, and Vitamin B-12 Deficiency: Clinical Implications.

Authors:  Joshua W Miller
Journal:  Adv Nutr       Date:  2018-07-01       Impact factor: 8.701

10.  Cobalamin deficiency, hyperhomocysteinemia, and dementia.

Authors:  Steven F Werder
Journal:  Neuropsychiatr Dis Treat       Date:  2010-05-06       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.